We provide you with 20 years of free, institutional-grade data for BCTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BCTX. Explore the full financial landscape of BCTX stock.
| Reported Date | CIK | Ticker | Type |
|---|
BriaCell Therapeutics Corp(NASDAQ:BCTX) 
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The ...
Website: http://www.briacell.com
Founded: 2006
CEO: Bill Williams
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about BCTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.